Abstract
Peripheral arterial disease most commonly affects the femoropopliteal segment. Despite enormous improvements in device and treatment technology the long-term patency rate and clinical benefit of endovascular treatment in the respective vascular bed is not satisfying. Drug coated balloon technology as a treatment option in femoropopliteal disease has shown encouraging results in first-in-man trials, which have now been proven in large randomized controlled trials.
MeSH terms
-
Angioplasty, Balloon / adverse effects
-
Angioplasty, Balloon / economics
-
Angioplasty, Balloon / instrumentation*
-
Cardiovascular Agents / administration & dosage*
-
Cardiovascular Agents / economics
-
Coated Materials, Biocompatible* / economics
-
Equipment Design
-
Femoral Artery* / physiopathology
-
Health Care Costs
-
Humans
-
Peripheral Arterial Disease / diagnosis
-
Peripheral Arterial Disease / economics
-
Peripheral Arterial Disease / physiopathology
-
Peripheral Arterial Disease / therapy*
-
Time Factors
-
Treatment Outcome
-
Vascular Access Devices* / economics
-
Vascular Patency
Substances
-
Cardiovascular Agents
-
Coated Materials, Biocompatible